CRAYON
Every story · every side  ·  est. 1995
Business

As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments

CRAYON summary

CNBC reports that an ongoing shortage of Sanofi's treatment for Pompe disease is forcing some patients to miss critical doses. According to CNBC, affected patients are struggling to access treatments and worry their health is at risk.

Based on CNBC's report - only one outlet has covered this so far. Read the original.
▲ Sign in to vote stories up

Coverage 1 source · 1 report

Chronological.

  1. CNBC FIRST 1h ago As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments

    An ongoing shortage of Sanofi’s Pompe disease treatment is forcing some patients to miss critical doses. They worry their health is at risk.

Discussion 0 comments